Medical Providers

Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-Analysis

Systematically reviews 156 trials, finding the best evidence of effectiveness for acamprosate, disulfiram, baclofen, and oral naltrexone among patients with alcohol use disorder supporting the expanded use of these medications in the clinical setting

Peers Speak Out: Priority Outcomes for Substance Use Treatment and Services

This is the first national examination of treatment and recovery services outcomes prioritized by people with substance use disorder, including recommendations for reshaping services, policies, and research to address the national epidemic of addiction.

Pahola

Pahola is PAHO's first artificial intelligence (AI) health specialist and the only AI digital health worker in the world that specializes in alcohol-related topics. Pahola can communicate interactively - in three languages (English, Portuguese, and Spanish) - with people about their alcohol consumption, assess their risk, help them reduce or stop alcohol use, or direct them to resources for treatment and recovery

One Degree: Shift the Influence

An update to AHRQ's systematic review protocol on outpatient pharmacotherapy for adults with alcohol use disorder in April 2022

Office for the Advancement of Telehealth: Telehealth Programs

This web page provides telehealth resources and programs available through the Office for the Advancement of Telehealth in the HRSA, including grant programs and services available in rural areas.

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Qualitative literature review that discusses disulfiram, acamprosate, naltrexone, nalmefene, topiramate, gabapentin, and several other medications for the treatment of alcohol use disorder, which have demonstrated some clinical effectiveness

Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes

Reviews the literature and data on outcomes for medication-assisted treatment for alcohol use disorder in inpatient settings using naltrexone

Mobile Health Interventions for Self-Control of Unhealthy Alcohol Use: Systematic Review

This study aimed to systematically review and synthesize the research evidence about the efficacy of mHealth interventions on various health outcomes for consumer self-control of unhealthy alcohol use and to identify the core components to achieve these outcomes

New Approved and Emerging Pharmacological Approaches to Alcohol Use Disorder: A Review of Clinical Studies

A review of the literature on clinical trials on pharmacotherapies for alcohol use disorder, noting that topiramate and gabapentin have been used and that baclofen and nalmefene have been approved in some other countries

National Institute on Alcohol Abuse and Alcoholism (NIAAA) Short Takes Video Series

A video series called “Short Takes with NIAAA” featuring commentary by NIAAA experts; this series consists of social media-friendly, 60-second videos explaining commonly used—but often misunderstood—alcohol terms

Subscribe to Medical Providers